Claims Analysis
Total Claims: 17
Claim 1
Independent Claim
87 words
A method of treating animals which method comprises administering to the animal an envelope having flexible water-permeable or porous walls and a given maximum non-stretched internal volume and containing a quantity of particulate water-insoluble hydrogel and a veterinarily active ingredient in sustained release form in the closed envelope wherein the volume of the quantity of hydrogel when fully swollen at 20° C. amounts to at least 66% of the given maximum non-stretched internal volume but is insufficient when fully swollen at 20° C. to rupture the envelope.
Claim 2
Independent Claim
87 words
A method of treating animals which method comprises administering to the animal an envelope having flexible water-permeable or porous walls and a given maximum non-stretched internal volume and containing a quantity of particulate water-insoluble hydrogel and a veterinarily active ingredient in sustained release form in the closed envelope wherein the volume of the quantity of hydrogel when fully swollen at 20° C. amounts to at least 66% of the given maximum non-stretched internal volume but is insufficient when fully swollen at 20° C. to rupture the envelope.
Claim 3
Dependent Claim
12 words
A method according to claim 1 wherein the animal is a ruminant.
Claim 4
Independent Claim
89 words
A method of treating a human patient which method comprises administering to the patient an envelope having flexible water-permeable or porous walls and a given maximum non-stretched internal volume and containing a quantity of particulate water-insoluble hydrogel and a pharmaceutically active ingredient in sustained release form in the closed envelope wherein the volume of the quantity of hydrogel when fully swollen at 20° C. amounts to at least 66% of the given maximum non-stretched internal volume but is insufficient when fully swollen at 20° C. to rupture the envelope.
Claim 5
Independent Claim
89 words
A method of treating a human patient which method comprises administering to the patient an envelope having flexible water-permeable or porous walls and a given maximum non-stretched internal volume and containing a quantity of particulate water-insoluble hydrogel and a pharmaceutically active ingredient in sustained release form in the closed envelope wherein the volume of the quantity of hydrogel when fully swollen at 20° C. amounts to at least 66% of the given maximum non-stretched internal volume but is insufficient when fully swollen at 20° C. to rupture the envelope.
Claim 6
Independent Claim
124 words
A device for sustained release of an active ingredient in the stomach of a human or animal, which device comprises an envelope having flexible water-permeable and porous walls of perforated plastic, knitted, braid or woven material, the envelope containing particulate water-insoluble hydrogel in a pharmaceutically, veterinarily or biologically active ingredient in sustained release form in the closed envelope wherein the volume of the hydrogel when fully swollen in water at 20° C. amounts to at least 66% of the maximum non-stretched internal volume of the envelope and is sufficient to retain the device within the stomach of the human or animal during the sustained release of the active ingredient but is insufficient when fully swollen in water at 20° C. to rupture the envelope.
Claim 7
Independent Claim
124 words
A device for sustained release of an active ingredient in the stomach of a human or animal, which device comprises an envelope having flexible water-permeable and porous walls of perforated plastic, knitted, braid or woven material, the envelope containing particulate water-insoluble hydrogel in a pharmaceutically, veterinarily or biologically active ingredient in sustained release form in the closed envelope wherein the volume of the hydrogel when fully swollen in water at 20° C. amounts to at least 66% of the maximum non-stretched internal volume of the envelope and is sufficient to retain the device within the stomach of the human or animal during the sustained release of the active ingredient but is insufficient when fully swollen in water at 20° C. to rupture the envelope.
Claim 8
Dependent Claim
31 words
The envelope according to claim 4, wherein the quantity of hydrogel when fully swollen in water at 20° C. amounts to at least 100% of the given maximum non-stretched internal volume.
Claim 9
Dependent Claim
14 words
The envelope according to claim 4, wherein the hydrogel is a crosslinked polyethylene glycol.
Claim 10
Dependent Claim
22 words
The envelope according to claim 4, which contains a mixture of hydrogel particles and particles of active ingredient in sustained release form.
Claim 11
Dependent Claim
20 words
The envelope according to claim 4, wherein the active ingredient in sustained release form is contained in the hydrogel particles.
Claim 12
Dependent Claim
34 words
The envelope according to claim 4, wherein the quantity of hydrogel when fully swollen in water at 20° C. ranges from 90 to 110% of the given maximum non-stretched internal volume of the envelope.
Claim 13
Dependent Claim
27 words
The envelope according to claim 4, wherein the average particle size of the hydrogel particles is at least 1% larger than the pores of the surrounding envelope.
Claim 14
Dependent Claim
24 words
The envelope according to claim 10, wherein said average particle size is at least twice the size of the pores of the surrounding envelope.
Claim 15
Dependent Claim
26 words
The envelope according to claim 4, wherein the hydrogel is one that upon swelling absorbs more than 40% of its dry weight of water without dissolution.
Claim 16
Dependent Claim
21 words
The envelope according to claim 12, wherein the degree of swelling of the hydrogel ranges between 150 and 1000% by weight.
Claim 17
Dependent Claim
14 words
The envelope according to claim 4, which is in the form of a toroid.